Thus, perturbations in the expression or retrograde transport of NGF, TrkA or p75NTR can underlie CBFN dysfunction and altered APP and tau processing in AD (Capsoni et al., 2002; Isacson et al., 2002). The gene discussed is APP; the disease is Alzheimer disease.